Taking a customer-first CRO through targeted acquisitions and US expansion

What does Veramed do?

Veramed is a UK-headquartered Clinical Research Organisation (CRO) that provides data management, biostatistics and programming services (collectively referred to as Biometrics) to pharmaceutical and biotech companies. Since it was founded in 2012, Veramed has grown organically and established a global presence, helping clients obtain the clinical data services they need to accelerate studies in a variety of therapeutic areas.

Industry leader, meet industry leader

We invested in Veramed in November 2021 after recognising that biometrics services were increasingly being outsourced to specialist firms such as Veramed rather than large ‘full-service’ CROs. It became clear to us there was considerable market share to be gained by a specialist CRO that could deliver significantly higher quality. Veramed fit this brief perfectly. When they began their search for investment to fund their US expansion, we demonstrated that we not only understood that Veramed’s unique culture was a competitive advantage to be protected at all costs, but that we had the network, expertise and insights to support them in transferring that winning culture to the US market.

Founder-led to global force

Following a prolonged period of target identification, outreach, and relationship building, led by Livingbridge, Veramed’s US expansion began in October 2023 with the acquisition of Boston CRO, Clinical Trial Data Services (CTDS). Just six months later, Veramed acquired BioPier, a notably larger CRO also based in the city.

Veramed is now an established global CRO with a strong foothold in the US market, having built a reputation for prioritising its staff, customers, and patients.

M&A remains a core part of Veramed's strategy, and Livingbridge continues to support a pipeline of targets and relationships, while actively looking for future acquisitions – all to position Veramed as the CRO of choice for the world's leading pharmaceutical and biotech companies.